| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.4M | +113.0% |
| SG&A Expense | $1.5M | +49.0% |
| Operating Income | -$3.9M | -81.1% |
| Net Income | -$4.0M | -85.1% |
| EPS (Basic) | -$0.01 | -75.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $212K | -81.8% |
| Current Assets | $255K | -78.9% |
| Total Assets | $1.1M | -39.8% |
| Current Liabilities | $639K | +28.7% |
| Total Liabilities | $3.5M | +7.1% |
| Stockholders' Equity | -$2.4M | -68.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.0M | +17.4% |
| Capital Expenditures | $138K | -36.1% |
| Investing Cash Flow | -$206K | +11.8% |
| Financing Cash Flow | $1.3M | -64.0% |
| Free Cash Flow | -$2.2M | +18.9% |